BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 18311788)

  • 1. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
    Mahendra A; Misra R; Aggarwal A
    J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
    Iwanami K; Matsumoto I; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
    Arthritis Res Ther; 2008; 10(6):R130. PubMed ID: 18992137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.
    Notley CA; McCann FE; Inglis JJ; Williams RO
    Arthritis Rheum; 2010 Jan; 62(1):171-8. PubMed ID: 20039431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.
    Egan PJ; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2008 Dec; 58(12):3720-9. PubMed ID: 19035489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
    Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
    Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses.
    Glatigny S; Blaton MA; Mencher SK; Mistou S; Lucas B; Fournier C; Wang LG; Chiocchia G
    Eur J Immunol; 2010 Feb; 40(2):460-9. PubMed ID: 20077403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; RĂ¼de E; Schmitt E
    J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.